Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra

NCT04120987 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Administrative

Conditions

Dry Eye

Interventions

DRUG: Lifitegrast 5% Ophthalmic Solution

Sponsor

Bucci Laser Vision Institute